DEBATE ON ADVANCED THERAPIES AND BIOLOGICAL MEDICINAL PRODUCTS

Jorge Muñoz, Member of CEFI Board lead the debate on advanced therapies an biological medicinal products. 

Sol Ruíz, Jefe de División de Productos Biológicos, Terapias Avanzadas y Biotecnología de la Agencia Española de Medicamentos y Productos Sanitarios and Jordi Faus, Abogado socio de Faus & Moliner Abogados debate about regulation, authorization an development of these products; study of the approved ones; the European Medicine Agency PRIME Scheme that provides early enhanced support to medicines, public financing challenges, no substitution; price differencial between original and biosimilar products; public contracting and their role in hospital enviroment,

Interesting theoretical and practical aspects on dvanced therapies and biological medicinal products.

This post is also available in: Spanish

Otras noticias

Promotion of Research through IP protection

Three of the most recognized experts on IP farma in Spain Ángel García Vidal, profesor de Derecho Mercantil de la Universidad de Santiago de Compostela y Consejero Académico de Gómez Acebo y Pombo, Kiko Carrión García de Parada, Abogado socio

Leer Más >>

Clinical Research and data protection debate

Interesting debate with Jesús Rubí, Adjunto a la Dirección de la Agencia Española de Protección de Datos, Amelia Martín Uranga, Responsable de la Plataforma de Medicamentos Innovadores de Farmaindustria and Lluis Alcover, Abogado de Faus y Moliner. Interestingf debate about main

Leer Más >>